Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
FALSE000173961400017396142023-05-302023-05-30UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-KCURRENT REPORT...
Inhibrx Granted Fast Track Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency PR...
FALSE000173961400017396142023-05-082023-05-08UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant...
Inhibrx Reports First Quarter 2023 Financial Results and Recent Corporate Highlights PR Newswire SAN DIEGO...
12/31FALSE00017396142023Q100017396142023-01-012023-03-3100017396142023-04-30xbrli:shares00017396142023-03-31iso4...
FALSE000173961400017396142023-04-252023-04-25UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-KCURRENT REPORT...
Inhibrx Initiates a Registration-Enabling Trial of INBRX-101 in AATD and Announces Lift of Partial Clinical...
UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 SCHEDULE 14A(RULE 14A-101)Schedule 14A INFORMATIONProxy Statement Pursuant...
Table of ContentsUNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 SCHEDULE 14A(RULE 14A-101)Schedule 14A INFORMATIONProxy...
FALSE000173961400017396142023-03-102023-03-10UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-KCURRENT REPORT...
As filed with the Securities and Exchange Commission on March 6, 2023REGISTRATION NO. 333 - UNITED STATESSECURITIES AND EXCHANGE...
Inhibrx Reports Fourth Quarter and Fiscal Year 2022 Financial Results PR Newswire SAN DIEGO, March 6, 2023 SAN...
FALSE00017396142022FYP3Y00017396142022-01-012022-12-3100017396142022-06-30iso4217:USD00017396142023-02-28xbrli:s...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지